12/2024 – The Malaysian Public Health Laboratories (Makmal Kesihatan Awam Kebangsaan) have awarded ADT Molecular the supply of our LyteStar™ Dengue Typing RT-PCR kit to the various centres in its network engaged in Dengue surveillance screening. The award follows the regulatory approval of the product by the Malaysian Medical Device Authority (MDA) earlier in the year and signifies another important milestone in showcasing our commitment to the Malaysian healthcare market, as well as underscoring its spearheading role as a BioNexus company in contributing value to the implementation of the National Biotechnology Policy 2.0, driven by Bioeconomy Corporation.
The LyteStar™ Dengue Typing RT-PCR Kit 1.0 is an in vitro diagnostic test system, based on real-time PCR technology, for the qualitative detection and differentiation of Dengue 1, Dengue 2, Dengue 3, and Dengue 4 virus (DENV1-4) specific RNA. The LyteStar™ Dengue Typing RT-PCR Kit 1.0 consists of a single tube assay targeting four genes; the 5’UTR/capsid gene specific for DENV1 and DENV4, envelope (E) gene specific for DENV2 and protein membrane (prM) gene specific for DENV3 genome.
